Adherence-adjusted estimates of benefits and harms from treatment with amoxicillin for LRTI: secondary analysis of a 12-country randomised placebo-controlled trial using randomisation-based efficacy estimators
David Gillespie(Cardiff University), Paul Little(University of Antwerp), Mark Mullee(University of Southampton), Theo Verheij(Utrecht University), Daniel Farewell(Cardiff University), Christopher Butler(University of Oxford), Kerenza Hood(NHS Digital), Beth Stuart(Queen Mary University of London), Herman Goossens(University of Antwerp)
Cited by 16
Related Papers
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
|The Lancet|2005|3.1k
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
|The Lancet|2005|1.4k
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
|New England Journal of Medicine|2015|1.2k
Guidelines for the management of adult lower respiratory tract infections - Full version
|Clinical Microbiology and Infection|2011|948
Language Ability after Early Detection of Permanent Childhood Hearing Impairment
|New England Journal of Medicine|2006|537